GSA CAPITAL PARTNERS LLP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,664
-20.0%
61,089
-34.6%
0.14%
-31.2%
Q2 2023$2,079
+3.5%
93,460
+0.8%
0.21%
+4.5%
Q1 2023$2,008
-20.4%
92,689
-25.4%
0.20%
-36.4%
Q4 2022$2,523
-99.6%
124,226
+374.0%
0.31%
+251.7%
Q3 2022$672,000
+92.0%
26,206
+78.2%
0.09%
+67.9%
Q2 2022$350,000
+31.6%
14,704
+24.5%
0.05%
+47.2%
Q1 2022$266,000
-36.1%
11,813
-44.2%
0.04%
-14.3%
Q3 2021$416,000
+9.8%
21,154
-32.5%
0.04%
-4.5%
Q4 2019$379,000
+11.8%
31,317
+30.5%
0.04%
-4.3%
Q3 2019$339,000
-34.3%
23,989
-45.4%
0.05%
-11.5%
Q1 2019$516,000
-32.5%
43,953
-23.1%
0.05%
-40.9%
Q4 2018$764,000
+135.1%
57,151
+146.3%
0.09%
+388.9%
Q3 2018$325,000
-81.1%
23,200
-78.8%
0.02%
-78.8%
Q2 2018$1,719,000
-45.6%
109,382
-43.1%
0.08%
-49.1%
Q1 2018$3,161,000
+102.1%
192,182
+122.0%
0.17%
+75.8%
Q4 2017$1,564,000
-46.4%
86,582
-42.8%
0.10%
-52.3%
Q3 2017$2,920,000
+158.2%
151,282
+57.8%
0.20%
+168.9%
Q2 2017$1,131,000
-70.1%
95,882
-72.2%
0.07%
-63.5%
Q1 2017$3,786,000
+36.2%
345,476
-9.7%
0.20%
+22.3%
Q4 2016$2,779,000
+11.1%
382,776
-0.6%
0.17%
+23.9%
Q3 2016$2,502,000
+10.7%
384,976
-7.0%
0.13%
+7.2%
Q2 2016$2,260,000
+99.1%
413,902
+70.6%
0.12%
+73.6%
Q1 2016$1,135,000
+102.0%
242,604
+114.9%
0.07%
+157.1%
Q4 2015$562,000
+185.3%
112,892
+115.1%
0.03%
+180.0%
Q3 2015$197,000
-73.5%
52,491
-57.5%
0.01%
-64.3%
Q2 2015$742,000123,4910.03%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders